medigraphic.com
Academia Mexicana de Neurología, A.C.

2006, Número 3

<< Anterior Siguiente >>

Rev Mex Neuroci 2006; 7 (3)


Actualidad sobre los ataques isquémicos transitorios III. Diagnóstico y tratamiento

Fernández CO

Idioma: Español
Referencias bibliográficas: 41
Paginas: 212-217
Archivo PDF: 72.00 Kb.


RESUMEN

Los ataques isquémicos transitorios (AIT) son trastornos episódicos y focales de la circulación cerebral y retiniana. Es muy importante la identificación oportuna, así como la evaluación etiológica y la terapéutica adecuada en pacientes que padecen esta enfermedad, ya que sólo así podrán prevenir la ocurrencia de un ictus. En la atención primaria de esta enfermedad por lo general es donde se presentan las deficiencias terapéuticas debido al desconocimiento que tiene la población sobre el AIT. Por tratarse de episodios de breve duración, la mayor parte de las veces el médico no asiste al cuadro y al examen físico en el momento inicial de la observación; esto es normal, por ello el diagnóstico clínico depende exclusivamente del interrogatorio. Finalmente, la neuroimagen será esencial para diferenciar otros procesos capaces de simularlo, los estudios neurosonológicos nos ayudarán a definir probable ateromatosis. La terapéutica debe depender de la etiología y otras condicionantes como el control de los factores de riesgo, los antiplaquetarios, la endarterectomía y la anticoagulación.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sherman DG. Reconsideration of TIA diagnostic criteria. Neurology 2004; 62: S20-S21.

  2. Dyken ML, Conneally M, Haerer AF, Gotshall RA, Calanchini PR, Poskanzer DC, Price TR, Swanson PD. Cooperative study of hospital frequency and character of transient ischemic attacks I. Background, organization, and clinical survey. JAMA 1977; 237(9): 882-6.

  3. Andre C, Vincent MB. On the pathogenesis of headache following TIA. Arq Neuropsiquiatr 1997; 55(2): 167-73.

  4. Larsen BH, Sorensen PS, Marquardsen J. Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation? A 10 year follow up study of 46 patients. J Neurol Neurosurg Psychiatry 1990; 53(12): 1029-33.

  5. Dennis M, Warlow C. Migraine aura without headache: transient ischaemic attack or not? J Neurol Neurosurg Psychiatry 1992; 55(6): 437-40.

  6. Fisch BJ, Tatemichi TK, Prohovnik I. Transient ischemic attacks resembling simple partial motor seizures. Neurology 1988; 38(S1): 264.

  7. Yanagihara T, Piepgras DG, Klass DW. Repetitive involuntary movement associated with episodic cerebral ischaemia. Ann Neurol 1985; 18: 244-50.

  8. Baquis GD, Pessin MS, Scott RM. Limb shaking-a carotid TIA. Stroke 1985; 16: 444-8.

  9. Tatemichi TK, Young WL, Prohovnik I. Perfusion insufficiency in limb-shaking transient ischemic attacks. Stroke 1990; 21: 341-7.

  10. Baumgartner RW, Baumgartner I. Vasomotor reactivity is exhausted in transient ischaemic attacks with limb shaking. J Neurol Neurosurg Psychiatry 1998; 65: 561-4.

  11. Niehaus L, Neuhauser H, Meyer BU. TIAs of hemodynamic origin mimicking simple partial motor seizures. Nervenarzt 1998; 69: 901-4.

  12. Klijn CJM, Kappelle LJ, van Huffelen AC, et al. Recurrent ischemia in symptomatic carotid occlusion. Prognostic value of hemodynamic factors. Neurology 2000; 55: 1806-12.

  13. Firlik AD, Firlik KS, Yonas H. Physiological diagnosis and surgical treatment of recurrent limb shaking: case report. Neurosurgery 1996; 39: 607-11.

  14. Kim JW, Choi SH, Kim WJ, Chun SM. Transient ischemic attacks presenting as hemiballism. Mov Disord 2003; 18(11): 1399-401.

  15. Delgado-Acosta F, Bravo-Rodriguez F, Ochoa-Sepulveda JJ, Bautista-Rodriguez MD. Ataque isquémico cerebral como única manifestación de una fistula arteriovenosa dural. Rev Neurol 2003; 37(10): 931-4.

  16. Gilhuis HJ, Kappelle AC, Swen JW, Vecht ChJ. Not every TIA is primarily vascular. Ned Tijdschr Geneeskd. 2003; 147(37): 1769-72.

  17. García Pastor A, Iniesta López I, de Andrés C. Tumores intracraneales que se manifiestan simulando ataques isquémicos transitorios. Rev Neurol 2001; 33(9): 839-42.

  18. Tushla MC, Waltke EA, Aita JF. Transient ischemic attack (TIA) secondary to subdural hematoma. Nebr Med J 1992; 77(10): 273-6.

  19. Ferro JM, Falcao I, Rodrigues G, Canhao P, Melo TP, Oliveira V, et al. Diagnosis of transient ischemic attack by the nonneurologist. A validation study. Stroke 1996; 27(12): 2225-9.

  20. Davidson E, Rotenbeg Z, Fuchs J, Weinberger I, Agmon J. Transient ischemic attack-related syncope. Clin Cardiol 1991; 14(2): 141-4.

  21. Nguyen-Huynh MN, Fayad P, Gorelick PB, Johnston SC. Knowledge and management of transient ischemic attacks among US primary care physicians. Neurology 2003; 61: 1455-6.

  22. Goldstein LB, Bian J, Samsa GP. New transient ischemic attack and stroke. Outpatient management by primary care physicians. Arch Intern Med 2000; 160: 2941-6.

  23. Albers GW, Yim JM, Belew KM. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch Intern Med 1996; 156: 2311-6.

  24. Benade MM, Warlow CP. Cost of identifying patients for carotid endarterectomy. Stroke 2002; 33: 435-9.

  25. Johnston SC. Transient Ischemic Attack. N Engl J Med 2002; 347(21): 1687-92.

  26. Aburahma AF, Thiele SP, Wulu JT Jr. Prospective controlled study of the natural history of asymptomatic 60% to 69% carotid stenosis according to ultrasonic plaque morphology. J Vasc Surg 2002; 36(3): 437-42.

  27. Rappeport Y, Simonsen L, Christensen H, Boysen G. Prevalence of significant carotid artery stenosis in patients with transient ischaemic attack. Med Sci Monit 2002; 8(5): CR317-20.

  28. Mayor I, Comelli M, Vassileva E, Burkhard P, Sztajzel R. Microembolic signals and carotid plaque morphology: a study of 71 patients with moderate or high grade carotid stenosis. Acta Neurol Scand 2003; 108(2): 114-7.

  29. Jiang Y, Hu J, Gao Q. An analysis on the diagnostic values of transcranial Doppler and angiography in transient ischemic attack. J Tongji Med Univ 2001; 21(2): 100-1.

  30. O’Rourke F, Dean N, Akhtar N, Shuaib A. Current and future concepts in stroke prevention. CMAJ 2004; 170(7): 1123-33.

  31. Albers GW, Hart RG, Lutsep HL. AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke 1999; 30: 2502-11.

  32. Barnett HJ, Taylor DW, Eliasziw M. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.

  33. Serafini O, Misuraca G, Greco F, Bisignani G, Manes MT, Venneri N. Prevalence of structural abnormalities of the atrial septum and their association with recent ischemic stroke or transient ischemic attack: echocardiographic evaluation in 18631 patients. Ital Heart J 2003; 4 (Suppl. 1): S39-S45.

  34. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003; 145(4): 676-82.

  35. Hart RG, Pearce LA, Koudstaal PJ. Transient Ischemic Attacks in Patients With Atrial Fibrillation. Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial. Stroke 2004; 35: 948.

  36. Yahia AM, Kirmani JF, Xavier AR, Shaukat A, Qureshi AI. Characteristics and predictors of aortic plaques in patients with transient ischemic attacks and strokes. J Neuroimaging 2004; 14(1): 16-22.

  37. van Goor MPJ, Alblas CL, Leebeek FWG, PJ Koudstaal, Dippel DWJ. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke? Acta Neurol Scand 2004; 109(6): 410-4.

  38. Janardhan V, Wolf PA, Kase CS, Massaro JM, D’Agostino RB, Franzblau, et al. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 2004; 35(3): 736-41.

  39. Amarenco P, Lavallée P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol 2004; 3: 271-8.

  40. Manktelow B, Gillies C, Potter JF. Interventions in the management of serum lipids for preventing stroke recurrence. Cochrane Database Syst Rev 2002; 3: CD002091.

  41. The SPARCL Investigators. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL). Cerebrovasc Dis 2003; 16: 389-95.




2020     |     www.medigraphic.com